Jun-Eul Hwang

chonnam national university

H指数:32

被引数:4,289

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Impact of 5-HTTLPR Polymorphism on Depression and Lymphocyte Changes in Colorectal Cancer Patients Undergoing FOLFOX Chemotherapy

5-HTTLPR多态性对接受FOLFOX化疗的结直肠癌患者抑郁和淋巴细胞变化的影响

Psychiatry Investigation

IF1.8

2026-02-010

Long-term Immunogenicity of the 13-valent Pneumococcal Conjugate Vaccine during Adjuvant Chemotherapy in Patients with Gastric and Colorectal Cancer: A 5-Year Follow-up of a Randomized Controlled Trial

十三价肺炎球菌结合疫苗在胃癌和结直肠癌患者辅助化疗期间的长效免疫原性：一项随机对照试验的5年随访

Cancer Research and Treatment

IF3.8

2026-01-010

OAAI

Prognostic factors of mortality in patients with cancer infected with COVID-19: A systematic review and meta-analysis using the GRADE approach

癌症合并COVID-19感染患者死亡率的预后因素：一项采用GRADE方法的系统评价与Meta分析

International Journal of Cancer

IF4.7

2025-10-170

PRE

FGFR4 promotes colon cancer progression through CAF activation via the CXCL10-CXCR3 axis

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis

FRONTIERS IN ONCOLOGY

IF3.3

2023-10-103

OAAI

Differences in referral patterns to the palliative care team among specialized physicians in patients with terminal cancer

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α-TAK1-MMP9 axis

LGALS3BP通过抑制TNF-α-TAK1-MMP9轴抑制三阴性乳腺癌的侵袭性

CELL DEATH DISCOVERY

IF7

2023-04-113

OAAI

Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenib

血清AFP在regorafenib治疗的肝细胞癌患者中的预后意义

FUTURE ONCOLOGY

IF2.6

2022-07-298

PRE

Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma

阿特珠单抗联合贝伐单抗在韩国晚期肝细胞癌患者中的疗效和安全性

LIVER INTERNATIONAL

IF5.2

2021-11-2945

PREAI

Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2021-11-1443

OAAI

TRIAL IN PROGRESS: A PHASE 2 STUDY TO ASSESS THE SAFETY, EFFICACY OF FLX475 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC GASTRIC CANCER

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2021-11-100

Intravesical gemcitabine for non-muscle invasive bladder cancer

COCHRANE DATABASE OF SYSTEMATIC REVIEWS

IF9.4

2021-06-1427

OAAI

Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling

CELL DEATH DISCOVERY

IF7

2021-04-0619

OAAI

Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study

Regorafenib治疗晚期Child-Pugh B级肝细胞癌的多中心回顾性研究

LIVER INTERNATIONAL

IF5.2

2020-07-0937

PREAI

Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy

SCIENTIFIC REPORTS

IF3.9

2020-06-1215

OAAI

Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events

LIVER INTERNATIONAL

IF5.2

2020-05-2533

PREAI

Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-07-2629

OAAI

EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment

ANNALS OF ONCOLOGY

IF65.4

2019-07-012

OAAI

TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma

CANCER LETTERS

IF10.1

2018-02-0117

PREAI

Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib

JOURNAL OF KOREAN MEDICAL SCIENCE

IF2.3

2018-01-0112

OAAI

Jun-Eul Hwang

个人简介

教育背景

工作经历

荣誉奖项

研究方向